Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
689
-
Total 13F shares, excl. options
-
136M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$12.5B
-
Value change
-
-$96.7M
-
Put/Call ratio
-
1.8
-
Number of buys
-
280
-
Number of sells
-
-387
-
Price
-
$91.82
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2021
907 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 689 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136M shares
of 176M outstanding shares and own 77.25% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (18.9M shares), VANGUARD GROUP INC (13.1M shares), BAILLIE GIFFORD & CO (10.9M shares), BlackRock Inc. (9.43M shares), Sumitomo Mitsui Trust Holdings, Inc. (9.14M shares), Nikko Asset Management Americas, Inc. (8.76M shares), BANK OF MONTREAL /CAN/ (3.37M shares), STATE STREET CORP (3.08M shares), CREDIT SUISSE AG/ (2.29M shares), and Discovery Value Fund (2.16M shares).
This table shows the top 689 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.